{"id":"4c0829a6-b49d-4634-ae6b-10246749afbe","kind":"institutions","code":"UB-I1502","name":"Zhongxinjian Investment Ben","nameBasis":"transliterated","summary":"Private equity investment platform under CSC Financial.","description":"Private equity investment platform under CSC Financial.","country":null,"category":null,"originalName":"中信建投资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:28.309Z","englishUpdatedAt":"2026-10-15T20:27:18.706Z","reviewedAt":"2026-10-15T20:27:18.706Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f872250e85db83bedc79f7520b140b3e333bd36cb7a26d3bbfdc57aa8222ee97","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"中信建投证券旗下私募股权投资平台。","sources":[],"related":[{"id":"b58f69cb-5ce0-4532-a04f-6b665435a460","kind":"news","code":"b58f69cb-5ce0-4532-a04f-6b665435a460","name":"Baiyang Intelligence raises RMB 300 million in Series A+ financing","nameBasis":"translated-title","summary":"On 2026-01-06, according to Xiniu Data, Baiyang Intelligence completed Series A+ financing, raising RMB 300 million. Investors were Xianjin Technology Chengguochangsanjiaozhuanhuazhongxin, Taiyayusong, Zhuoyuan Fund, Haitong Innovation and others.","description":"","country":null,"category":null,"originalName":"白杨智能完成A+轮融资，金额3亿人民币","eventDate":"2026-01-06T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-16T19:46:28.925Z","englishUpdatedAt":"2026-10-20T18:21:37.786Z","reviewedAt":"2026-10-20T18:21:37.786Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"d4d85a80f0b75b6068be4ff3c4ffb9d09de15e1dfb565019f4f110d9788208bb","companyId":"98b864bf-3649-43b8-bf2a-caf0844e8b3a","foundedYear":null,"logoUrl":null,"path":"/news/b58f69cb-5ce0-4532-a04f-6b665435a460"},{"id":"9c0aa09f-a2ea-4843-bdb0-6934662ac60c","kind":"news","code":"9c0aa09f-a2ea-4843-bdb0-6934662ac60c","name":"INLINBOT completes Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"盈连科技完成A轮融资","eventDate":"2025-08-22T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-13T17:03:31.444Z","englishUpdatedAt":"2026-10-15T17:19:59.781Z","reviewedAt":"2026-10-15T17:19:59.781Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0a94bf03ab5d2249b0c55b4b772bedaf55916792116e5fc3ee2f21d965193943","companyId":"07cdb401-7306-4f6c-b86b-7f32e0c9a628","foundedYear":null,"logoUrl":null,"path":"/news/9c0aa09f-a2ea-4843-bdb0-6934662ac60c"},{"id":"17bde15d-88bb-40f4-9891-9fa21b1770a8","kind":"news","code":"17bde15d-88bb-40f4-9891-9fa21b1770a8","name":"Kunlunxin completes strategic financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"昆仑芯完成战略投资融资","eventDate":"2024-12-24T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:38:19.350Z","englishUpdatedAt":"2026-10-15T17:19:59.272Z","reviewedAt":"2026-10-15T17:19:59.272Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"c67a499c4dd49b3ff067bfc72a3d2deba36e3948ff4deb866dc3990ce9ace3bc","companyId":"90dca3ec-e6cd-4751-9b6d-d0cde6684692","foundedYear":null,"logoUrl":null,"path":"/news/17bde15d-88bb-40f4-9891-9fa21b1770a8"},{"id":"f14a5ba5-7560-4966-8935-a5118be9f21d","kind":"news","code":"f14a5ba5-7560-4966-8935-a5118be9f21d","name":"Wuwenxinqiong raises RMB 700 million in equity financing","nameBasis":"translated-title","summary":"On 2026-05-07, according to Xiniu Data, Wuwenxinqiong completed equity financing, raising RMB 700 million. Investors were co-lead investor Gaoxinjintou Group, co-lead investor Huiyuan Capital, Guoxing Capital, Qinhuai Data and others. The company is a provider of heterogeneous AI computing infrastructure.","description":"","country":null,"category":null,"originalName":"无问芯穹完成股权投资融资，金额7亿人民币","eventDate":"2026-05-07T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:18:23.407Z","englishUpdatedAt":"2026-10-20T18:23:00.915Z","reviewedAt":"2026-10-20T18:23:00.915Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"fdb565dc3348dd01824086f9349cd48b755e3c18b6914c3aa556e5913156d69c","companyId":"cded3749-2115-4e4c-b70f-3796c50c30c3","foundedYear":null,"logoUrl":null,"path":"/news/f14a5ba5-7560-4966-8935-a5118be9f21d"},{"id":"87d34afd-f68f-49ea-b268-950d45d15687","kind":"news","code":"87d34afd-f68f-49ea-b268-950d45d15687","name":"Xinuoweilai Xynova raises hundreds of millions of RMB in Series A financing","nameBasis":"translated-title","summary":"On 2026-05-29, according to Xiniu Data, Xinuoweilai Xynova completed Series A financing, raising hundreds of millions of RMB. Investors were co-lead investor Lixiangqiche, co-lead investor Zhongxinjian Investment Ben, co-lead investor Zhongxinjiantou Investment, Changsanjiaoshuwen and others. The company is a supplier of core components for humanoid robots.","description":"","country":null,"category":null,"originalName":"曦诺未来Xynova完成A轮融资，金额数亿人民币","eventDate":"2026-05-29T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:24:25.210Z","englishUpdatedAt":"2026-10-20T18:21:37.596Z","reviewedAt":"2026-10-20T18:21:37.596Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"03cb3471631abb8ca1b6fc98ff89607cb391ec2d7c153af3f86210bac309669f","companyId":"e99f2f33-0799-440a-a128-fef067bf0382","foundedYear":null,"logoUrl":null,"path":"/news/87d34afd-f68f-49ea-b268-950d45d15687"},{"id":"48c7fbb5-da1d-4d8f-8891-16287b8388df","kind":"news","code":"48c7fbb5-da1d-4d8f-8891-16287b8388df","name":"iRegene raises RMB 260 million in Series C+ financing","nameBasis":"translated-title","summary":"On 2026-07-02, according to Xiniu Data, iRegene completed Series C+ financing, raising RMB 260 million. Investors were lead investor Chengdu Ke Venture Capital, participating investor Zhongxinjian Investment Ben, participating investor Xi Venture Capital, participating investor Dingtaixing, participating investor Xinjiye, participating investor Hongyi Capital, participating investor Yuanxihaihe (Tianjin) Biotechnology Pharmaceutical Industry Fund Partnership (Limited Partnership). The company is a developer of chemically induced cell therapy drugs.","description":"","country":null,"category":null,"originalName":"睿健医药完成C+融资，金额2.60亿人民币","eventDate":"2026-07-02T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:18:19.314Z","englishUpdatedAt":"2026-10-20T18:21:37.336Z","reviewedAt":"2026-10-20T18:21:37.336Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"952c547ad5eb57bf8d1dbe53be1cab5e2540393b32284532c5147f6372db89f6","companyId":"c6f40f74-5248-4720-8404-fd1e03022e90","foundedYear":null,"logoUrl":null,"path":"/news/48c7fbb5-da1d-4d8f-8891-16287b8388df"}],"path":"/institutions/zhongxinjian-investment-ben","displayName":"中信建投资本","displayNameLang":"zh","structured":{"city":null,"country":"China (mainland)","location":null,"role":null,"category":null,"company":null},"definition":"中信建投资本 is a private equity investor based in China (mainland) with 6 recorded investments in 6 companies.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/zhongxinjian-investment-ben"}